Results 231 to 240 of about 180,829 (383)

The Dual Mechanism of Action of CO-005 Overcomes CD20 Resistance in Diffuse Large B-Cell Lymphoma. [PDF]

open access: yesImmunotargets Ther
Matar S   +7 more
europepmc   +1 more source

CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells

open access: green, 2009
D. Parolini   +11 more
openalex   +2 more sources

Harnessing Digital Pathology Tools to Distinguish Hand Eczema From Palmar Psoriasis: A Quantitative Approach

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Distinguishing hand eczema from palmar psoriasis is a common diagnostic challenge due to overlapping clinical and histopathological features. Objective This study aimed to validate morphological and immunohistochemical criteria for differentiating these two conditions using the digital pathology tools QuPath and ImageJ.
Melissa Sari   +8 more
wiley   +1 more source

Incidence of severe COVID‐19 in patients with chronic lymphocytic leukaemia or indolent B‐cell non‐Hodgkin lymphoma who received vaccination and pre‐exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the GIMEMA working party on chronic lymphoproliferative disorders and by the Fondazione Italiana Linfomi

open access: yes
British Journal of Haematology, EarlyView.
Gian Matteo Rigolin   +25 more
wiley   +1 more source

Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption – A prospective monocenter pilot study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the Western world. While remission is achieved in the majority of BP patients by long‐term use of corticosteroids with or without immunomodulants/immunosuppressants, national and international guidelines recommend adjuvant immunoadsorption (IA)
Maike M. Holtsche   +7 more
wiley   +1 more source

Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study. [PDF]

open access: yesBMJ Neurol Open
Rasmussen TH   +21 more
europepmc   +1 more source

Canine CD20 gene

open access: yesCanine CD20 gene
The human CD20 antigen, a 35 kDa cell surface nonglycosylated hydrophobic phoshpoprotein is expressed consistently on almost all human B-cells, and its monoclonal antibody is used for the therapy on human B-cell lymphoma. In the present study, canine CD20 gene was cloned and sequenced, and the expression of CD20 mRNA was investigated in canine ...
openaire  

Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach

open access: gold, 2018
Mathilde R. W. de Jong   +10 more
openalex   +2 more sources

Anti‐CD20 treatment in Primary Sjögren’s Syndrome [PDF]

open access: bronze, 2008
Kjetil Isaksen   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy